A Clinical Study of TA-4708 in Patients with Chronic Atrial Fibrillation

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221522

Enrollment

Registered

2011-07-28

Start date

2011-07-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic atrial fibrillation

Interventions

investigational material(s) Generic name etc : TA-4708 (Bisoprolol Fumarate) INN of investigational material : Therapeutic category code : 212 Antiarrhythmic agents Dosage and Administration for Inve

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with chronic (persistent or permanent) atrial fibrillation 2. Resting heart rate: >=80 bpm

Exclusion criteria

Exclusion criteria: 1. Patients with a history of myocardial infarction within 6 months 2. Patients with cardiac failure, cardiomyopathy, cardiogenic shock, or myocarditis, or reduced cardiac function 3. Patients with a history of apoplectic insult or cerebrovascular accident, etc.

Design outcomes

Primary

Measure	Time frame
Change in heart rate	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026